Developmental neuron death is well described in sensory and sympathetic ganglia derived from the neural crest. In this study, nodose ganglia were removed from 2 litters of postnatal rats (male and female; 1, 3, 5, 9, and 14 days old) in order to determine whether postnatal nevron degeneration occurs in the nodose ganglia, which is derived from ectodermal placode. The ganglia were embedded in paraffin, sectioned and stained with methylene blue. Neuronal nuclei were counted at a magnification of 100 and diameters of nodose nuclei were traced at each age. There was a significant (p < 0.001) increase in the nuclear diameter of the nodose neurons of male and female rats from birth to postnatal day 14. In male rats, this difference was most marked between postnatal day 5 and postnatal day 14. The results of the neuron counts for both male and female rats indicated a gradual, significant (p < 0.001) decrease in the neuron population from day 1 to 14. For the males a 57.2% decline was observed, while the females displayed a 49.2% decline. The numbers of neurons in male and female ganglia showed no consistent differences. The data for neuron counts suggest that developmental neuron death occurs in postnatal rats with a gradual decrease in number of nodose neurons. However, since our findings show no evidence of degenerating nodose neurons, we are unable to rule out the possibility of migration from the developing ganglion.

Keywords:
Ganglia, sensory and sympathetic, Nevron death, Nodose ganglia
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.